Hutten B A, Lensing A W, Kraaijenhagen R A, Prins M H
Department of Clinical Epidemiology and Biostatistics, University of Amsterdam, The Netherlands.
Drugs Aging. 1999 Apr;14(4):303-12. doi: 10.2165/00002512-199914040-00005.
Oral anticoagulants have documented efficacy for many indications and are widely used in elderly patients. However, there is concern about whether this treatment induces an excess of major bleeding in elderly patients. In this systematic review, the incidence of oral anticoagulant-related major bleeding among elderly patients was determined. A total of 58 reports were identified that evaluated an oral anticoagulant, included patients with a mean age of at least 60 years, and provided data on the occurrence of major bleeding or provided separate data on the occurrence of major bleeding in elderly versus younger patients. In 50 studies no age differentiation was given. Although the incidence of bleeding complications varied, a trend towards increased bleeding with increasing age was shown in patients with major orthopaedic surgery and cardiac diseases. In the 8 articles that provided separate data on the occurrence of bleeding in different age categories, there was a clear tendency towards a 2-fold increase in bleeding in elderly patients. These findings emphasise the need for caution in the use of oral anticoagulants in elderly patients. However, the decision to start oral anticoagulant treatment should be based on an evaluation of the risk/benefit balance on a careful patient-by-patient basis. In general, if oral anticoagulant treatment is started, the lowest possible effective International Normalised Ratios (INR) should be selected and regular monitoring should be done to avoid over-anticoagulation.
口服抗凝剂对多种适应症已被证明有效,并广泛应用于老年患者。然而,人们担心这种治疗是否会在老年患者中导致过多的严重出血。在这项系统评价中,确定了老年患者中口服抗凝剂相关严重出血的发生率。共识别出58篇报告,这些报告评估了一种口服抗凝剂,纳入了平均年龄至少60岁的患者,并提供了严重出血发生情况的数据,或提供了老年患者与年轻患者严重出血发生情况的单独数据。在50项研究中未给出年龄差异。尽管出血并发症的发生率各不相同,但在接受重大骨科手术和患有心脏病的患者中,显示出随着年龄增长出血有增加的趋势。在8篇提供不同年龄组出血发生情况单独数据的文章中,老年患者出血明显有增加两倍的趋势。这些发现强调了在老年患者中使用口服抗凝剂时需要谨慎。然而,开始口服抗凝剂治疗的决定应基于对每位患者仔细的风险/获益平衡评估。一般来说,如果开始口服抗凝剂治疗,应选择尽可能低的有效国际标准化比值(INR),并应进行定期监测以避免抗凝过度。